KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Acquisitions & Divestments: 2009-2024

Historic Change in Acquisitions & Divestments for Novavax (NVAX) over the last 14 years, with Dec 2024 value amounting to $443.6 million.

  • Novavax's Change in Acquisitions & Divestments fell 4.84% to $100.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $593.1 million, marking a year-over-year increase of 58.37%. This contributed to the annual value of $443.6 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Novavax's Change in Acquisitions & Divestments is $443.6 million, which was up 177.55% from $159.8 million recorded in FY2021.
  • In the past 5 years, Novavax's Change in Acquisitions & Divestments ranged from a high of $443.6 million in FY2024 and a low of $159.8 million during FY2021.
  • Its 1-year average for Change in Acquisitions & Divestments is $443.6 million, with a median of $443.6 million in 2024.
  • As far as peak fluctuations go, Novavax's Change in Acquisitions & Divestments spiked by 420.41% in 2020, and later declined by 22.26% in 2021.
  • Novavax's Change in Acquisitions & Divestments (Yearly) stood at $205.6 million in 2020, then declined by 22.26% to $159.8 million in 2021, then reached $443.6 million in 2024.